Paper560239
The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain.
Höllt V and 2 others. Brain Res, 1977. Cited by 83 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain. Papers, record 560239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/560239
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Receptors, Drug | Major topic |
| Tranquilizing Agents | Major topic |
| Animals | |
| Apomorphine | |
| Catalepsy | |
| Chlorpromazine | |
| Dibenzocycloheptenes | |
| Dopamine | |
| Haloperidol | |
| Humans | |
| Male | |
| Mice | |
| Piribedil | |
| Quinolizines | |
| Receptors, Dopamine | |
| Spiperone | |
| Structure-Activity Relationship |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,112,768 | Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6112768 | PubMed |
| 4,040,216 | Effects of discriminant and non-discriminant dopamine antagonists on in vivo accumulation of 3H-N-propyl-norapomorphine in mouse striatum and tuberculum olfactorium. | Naunyn Schmiedebergs Arch Pharmacol | 1985 | https://conductscience.org/library/papers/4040216 | PubMed |
| 3,873,656 | Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3873656 | PubMed |
| 2,968,911 | PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain. | Eur J Nucl Med | 1988 | https://conductscience.org/library/papers/2968911 | PubMed |
| 2,882,801 | Pharmacological characterization of binding sites identified in rat brain following in vivo administration of [3H]-spiperone. | Br J Pharmacol | 1987 | https://conductscience.org/library/papers/2882801 | PubMed |
| 1,678,266 | Difference in in vivo receptor binding between [3H]N-methylspiperone and [3H]raclopride in reserpine-treated mouse brain. | J Neural Transm Gen Sect | 1991 | https://conductscience.org/library/papers/1678266 | PubMed |
| 658,293 | Specific in vivo binding of d-LSD in rat brain. | Experientia | 1978 | https://conductscience.org/library/papers/658293 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/560239
GET https://conductscience.org/api/papers/v1/560239/authors